FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Rocket Pharmaceuticals, Inc.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2023-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/8df8086f-627d-4184-b9fa-db8b58bf0d8b

Reported value

$64.579M{"amount": 64579000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
Rocket Pharmaceuticals, Inc.
Metric
cash_and_equivalents
Period
as of 2023-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001140361-23-023233 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T12:11:34.883859+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001281895/cash-and-equivalents/2023-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.